The aim of this study was to identify the incidence of severe retinopathy of prematurity (ROP) requiring laser treatment and the overall incidence of ROP in extremely low birth weight (ELBW) infants, and to evaluate the associated risk factors for developing severe ROP in ELBW infants in Turkey.
Background
Retinopathy of prematurity (ROP) is a vasoproliferative disease of the retina that affects preterm neonates and is thought to be mediated by alterations in insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF) [1] . ROP is one of the major causes of avoidable childhood blindness in developed and developing countries. Approximately 50 000 children worldwide have ROP-related blindness [2] . The increase in survival rates in extremely low birth weight (ELBW) infants due to improvements in neonatal intensive care has resulted in an increased risk of developing ROP [3] . However, some studies report that improvements in neonatal intensive care have resulted in a decrease in the incidence of ROP [4, 5] . Nonetheless, it is known that ROP develops most frequently and most severely in ELBW infants [6] .
Recent studies report many systemic risk factors (respiratory distress syndrome, sepsis, necrotizing enterocolitis, intraventricular hemorrhage, and blood transfusion for neonatal severe anemia) associated with ROP [7] [8] [9] . The probable cause of the severity of ROP in ELBW infants could be associated with the risk factors stated above. The aim of the present study was to determine the incidence of severe ROP requiring laser treatment and the overall incidence of ROP, and to evaluate the risk factors for developing severe ROP requiring laser treatment in ELBW infants in Turkey.
Material and Methods
This retrospective, case-control study included preterm infants that presented to the ROP Screening, Treatment, and Training Center, Department of Ophthalmology, Etlik Zubeyde Hanim Maternity and Women's Health Research Hospital, Turkey, between January 2010 and April 2013. This study followed the tenets of the Declaration of Helsinki. The study protocol was approved by the Etlik Zubeyde Hanim Maternity and Women's Health Research Hospital Institutional Review Board. All infants with a gestational age of <32 week at birth were screened for ROP. The first examination was at a postnatal age of 4 weeks, but in the most immature infants (gestational age <27 weeks), the first examination was postponed until a postnatal age of 31 weeks. All preterm infants with a birth weight £1000 g were included in this study. All associated systemic findings; including blood culture-proven sepsis, respiratory distress syndrome (RDS), necrotizing enterocolitis (NEC), intraventricular hemorrhage (IVH), blood product transfusion, and patent ductus arteriosus (PDA) were recorded. Pupils were dilated using 2 drops of cyclopentolate/tropicamide 0.5% and phenylephrine 2.5% at 10-min intervals. After pupils were dilated, ophthalmological examination was performed using a pediatric eye speculum and pediatric scleral depressor, following instillation of 0.5% proparacaine eye drops for topical anesthesia. Indirect ophthalmoscopy was performed using a binocular indirect ophthalmoscope with a 20 and/or 28 diopter lens. The ROP status of each infant was classified according to the International Classification of ROP, including stage, zone, and extent of disease, and presence or absence of plus disease [10] . Infants with ROP were routinely re-examined every few days to 2 weeks, depending of the zone and severity of ROP [11] . Infants requiring laser photocoagulation treatment were identified based on Early Treatment for Retinopathy of Prematurity Randomized Trial criteria [12] . Accordingly, patients with type 1 ROP (severe ROP), defined as zone 1 any stage ROP with plus disease, zone 1 stage 3 ROP without plus disease, and zone 2 stage 2 or 3 ROP with plus disease, were referred for treatment. A wait-and-watch policy was used for type 2 ROP defined as zone 1 stage 1 or 2 ROP without plus disease, and zone 2 stage 3 ROP without plus disease. Patients diagnosed with type 1 disease were immediately referred for laser photocoagulation (Iridex OcuLight SL/SLx 810 nm diode laser, Mountain View, CA, USA) treatment the same day. The highest stage of ROP during followup examination was recorded for each infant. The other variables recorded were birth weight (BW), gestational age (GA), sex, presence of RDS, presence of blood culture-proven sepsis, presence of NEC, presence of IVH, and presence of PDA. These variables were recorded to compare screened infants that had ROP and those that did not. The patients with ROP were further divided into 2 subgroups: ROP cases not requiring laser treatment and ROP cases that received laser treatment. The variables were compared between the 3 groups (infants without ROP, infants with ROP that did not require laser treatment, and infants with ROP that received laser treatment).
Statistical analysis
Statistical analysis was performed using SPSS v.16.0 for Windows (SPSS, Inc. Chicago, IL, USA). Continuous variables are presented as mean ± SD; categorical variables are expressed as number and percentage. The Kolmogorov-Smirnov test was used to analyze the normality of data distribution. Descriptive statistics, such as frequencies of NEC, PDA, IVH, blood transfusion, RDS, and sepsis, were analyzed. Mean gestational weight and gestational age at birth were compared between groups using Kruskal-Wallis analysis. The chi-square test was used to compare categorical data related to clinical outcome. Univariate analysis was conducted to assess other potential risk factors for stage 3 ROP requiring laser treatment, such as sex, sepsis, blood transfusions, IVH, PDA, and NEC. To control for all of the variables and estimate the independent significant risk factors associated with stage 3 ROP requiring laser treatment, the factors were entered into a logistic regression multivariate analysis using a stepwise model. The level of statistical significance was set at P<0.05. The adjusted odds ratio (OR) and 95% confidence interval (CI) for each possible risk factor were calculated.
Results
In total, 235 infants weighing <1000 g were included in the study. Mean birth weight and mean gestational age were 858.31±107.45 g (range: 570-1000 g) and 27.08±1.99 weeks (range: 23-33 weeks), respectively. In all, 129 of the infants were female (54.9%) and 106 were male (45.1%). Among the patients, 48 (20.4%) developed culture-proven sepsis, 147 (62.5%) received surfactant and/or required oxygen therapy due to RDS, 12 (5.1%) developed IVH, 11 (4.7%) had NEC, 54 (22.9%) developed PDA, and 53 (22.5%) received blood transfusions. All baseline characteristics and associated systemic findings in the study population are summarized in Table1.
In overall, 62 (26.4%) patients did not develop any stage of ROP. Mean birth weight and gestational age in the infants without ROP were 915.56±81.27 g (range: 600-1000 g) and 28.34±1.91 weeks (range: 25-33 weeks), respectively; the male-to-female ratio was 0.82 (28/34).
Among the patients developing any stage of ROP, 37.02% (n=87) did not require laser treatment. In total, 61 (25.9%) patients developed stage 1 ROP and 26 (11.06%) developed stage 2 ROP. Mean birth weight and gestational age in the ROP patients that did not require laser treatment were 862.87±101.24 g (range: 600-1000 g) and 27.06±1.96 weeks (range: 23-33), respectively, and the male-to-female ratio was 0.64 (34/53).
There were 86 patients (36.6%) that received laser treatment due to severe ROP or type 1 ROP. Mean birth weight and gestational age in these patients were 816.33±110.68 g (range: 570-1000 g) and 26.28±1.65 weeks (range: 23-32), respectively, and the male-to-female ratio was 1.04 (44/42). There were 21 patients with aggressive posterior ROP, of which 3 had diode laser treatment and progressed to stage 4 ROP. These 3 patients had vitreoretinal surgery. Other laser-treated eyes with signs of severe ROP showed disease regression during the first week and the regression was almost complete at 1 month after the laser therapy. The differences between number of ROP distributions, mean gestational weight, and mean gestational age at birth in the 3 groups were statistically significant (KruskallWallis Analysis P<0.05). The number and percentage of patients without ROP, and those with ROP not requiring and received laser, and their gender distribution and associated systemic findings are shown in Table 2 . Table 3 summarizes the mean gestational age and mean gestational weight in the patients without ROP, those with ROP not requiring and requiring laser treatment, and the entire study population.
According to univariate analysis, the only significant risk factor for the presence of any stage ROP in ELBW infants was gestational age at birth (P=0.046), but the main risk factors for ROP requiring laser treatment were low gestational age at birth (P=0.008), low gestational weight at birth (P=0.011), culture-proven sepsis (P=0.017), and blood product transfusion (P=0.0001). The other associated systemic findings, including the presence of NEC (P=0.38), presence of PDA (P=0.33), and presence of RDS (P=0.35) and any stage IVH (P=0.43), were not associated with severe ROP. Univariate analysis showed that there was a significant relationship between ROP requiring laser treatment, and low gestational age, low gestational weight, sepsis, and blood transfusions. These risk factors were entered into multivariate logistic regression analysis via the stepwise (likelihood ratio) method, in which these 4 variables (low gestational age, low gestational weight, sepsis, and blood transfusions) were identified as weak (according to low ORs) but statistically significant (p<0.05) independent risk factors for severe ROP according to the P values and correlation based on adjusted ORs (Table 4) . A strong association was observed between blood transfusion and severity of ROP (adjusted OR: 2.165). Gestational age at birth (adjusted OR: 1.410; 95% CI: 1.175-1.694), gestational weight at birth (adjusted OR: 1.115; 95% CI: 1.112-1.118), culture-proven sepsis (adjusted OR: 0.464; 95% CI: 0.218-0.989) were weak (due to low ORs) but statistically significant (p<0.05) factors predictive of severe ROP (Table 4) .
Discussion
According to earlier studies, the number of extremely premature infants that survive has been increasing as neonatal care improves [13] [14] [15] [16] . It has also been reported that extremely premature infants have a higher risk of developing severe ROP requiring treatment than do more mature infants [8, [17] [18] [19] . The Early Treatment for Retinopathy of Prematurity (ETROP) study reported that the incidence of ROP was 82.5% in infants with a birth weight <1000 g, and that treatment was required in 92.4% of infants that weighed <1000 g [15] . According to the Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) study, ³81.6% infants that weighed <1000 g at birth developed ROP [20] . Kumar 
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with a birth weight <1000 g had ROP [21] . Lorenz et al. noted ROP in 62.1% of infants with a birth weight <1000 g [22] . A multicenter study by Zin et al. reported that 61.9% of infants with a birth weight <1000 g had severe ROP [23] and Choo et al. found that 58.6% of infants weighing <1000 g at birth developed ROP [24] . A recent study from China reported 64% of infants with a birth weight <1000 g developed any stage ROP [25] . In the present study, 73.6% of infants had ROP, which is similar to the rates reported by other Turkish referral centers of 70.7% [26] and 75.6% [27] , but lower than that in extremely premature Japanese infants (86.1%) [28] .
The rate of type 1 ROP requiring laser treatment among 235 ELBW infants in the present study was 36.6%; only 1 study (by Hiraoka et al.) reported a higher percentage of ELBW infants with severe ROP requiring laser treatment (41%) [28] . The incidence of type 1 ROP in ELBW infants was reported as 36.4% by Gharaibeh et al. [29] and Wani et al. [30] , which is similar to the rate in the present study. Choo et al. reported that 32.9% of ELBW infants reached a stage of ROP requiring laser treatment [24] . An earlier Turkish retrospective cohort study observed that 30.2% of ELBW infants who had advanced ROP required laser treatment [26] . Fortes et al. reported that 48.9% of ELBW infants in southern Brazil developed threshold ROP requiring laser treatment [19] ; however, a study conducted in China [31] reported that the incidence of ROP requiring laser treatment was 28.6%, in contrast to 28.7% in a study of ELBW infants conducted in the USA [32] . A Canadian study reported that the overall incidence of stage ³3 ROP in ELBW infants was 17.3% [6] . The lowest incidence of ROP requiring laser treatment in ELBW infants was reported from Brazil (12.7%) [33] . The variation in the reported incidence of severe ROP in the literature is due to numerous factors such as low birth weight (BW), low gestational age (GA), sex, presence of respiratory distress syndrome (RDS), presence of blood culture-proven sepsis, presence of necrotizing enterocolitis (NEC), presence of intraventricular hemorrhage (IVH), and presence of patent ductus arteriosus (PDA) [34] .
Also, we think the high incidence of severe ROP in the present study was primarily due to the fact it was conducted in a tertiary referral center that treats ROP patients requiring laser treatment from all over Turkey, and that most of the patients that admitted to our clinic were sick infants and at high-risk for developing severe ROP.
In the present study, low gestational age at birth was a significant risk factor for developing any stage of ROP, according to univariate analysis. Mean gestational age at birth was 28.34±1.91 weeks in the infants without ROP vs. 26.65±1.84 weeks in those with ROP. When the patients in the present study were divided into 2 subgroups according to gestational age at birth (£25 weeks vs. ³26 weeks), 90% (45/50) of the ELBW infants delivered at £25 weeks developed ROP vs. 88% in a study by Isaza et al. [6] and 87% in a study by Teed et al. [35] . These similar percentages are in agreement with the general knowledge that prematurity plays an important role in the pathogenesis of ROP [34, [36] [37] [38] [39] [40] [41] [42] . In the present study, the severity of ROP was inversely related to gestational age at birth (P=0.008) and gestational weight at birth (P=0.011), based on univariate and multivariate logistic regression analyses. Because gestational age at birth decreased, the duration of assisted ventilation and the likelihood of development of severe ROP increased [43] . Shah et al. reported that extreme low birth weight (<1000 g) and extreme prematurity (<30 weeks) were the main risk factors for developing severe ROP [44] , and Fortes et al. reported that one of the main risk factors for severe ROP in their retrospective ELBW infant cohort was gestational age at birth [33] ; the present findings are in agreement with these earlier findings.
Univariate analysis and multivariate logistic regression analysis showed that various systemic risk factors, such as the presence of culture-proven sepsis and blood transfusion, were strongly correlated with the development of severe ROP in the present study. Previous reports on very low birth weight infants reported ³1 of these risk factors, but the present study is the first to report the pathogenic role of these factors in ELBW infants; clinicians must be aware of the importance of these risk factors in ELBW infants and that they can result in severe ROP [44] .
Araz et al. reported that there was a strong association between the presence of ROP (as well as severe ROP) and sepsis [45] . Weintraub et al. noted that sepsis increases the risk of developing ROP 12-fold; they hypothesized that sepsis might increase oxygen demand and interfere with oxygen tension, which might increase retinal ischemia, resulting in ROP [46] . In the present study sepsis was an important and significant predictor of developing severe ROP.
Blood transfusion was the most important significant associated risk factor for developing severe ROP in the present study. Earlier studies have reported that blood transfusion is a significant risk factor for the development of threshold disease [42, 47] . Weintraub et al. reported that blood transfusion may be considered a clinical marker for the development of stage ³3 ROP; they reported that the incidence of stage 3 ROP was 14-fold higher in their neonates that received blood transfusions, and posited that it might have been because the high oxygen concentration of the transfused blood may have had toxic effects on the immature peripheral retinal vessels. They also found that a reduction in blood transfusions led to a reduction the incidence of severe ROP [46] .
Conclusions
In the present study, the severity of ROP was inversely correlated with birth weight and gestational age at birth, and positively correlated with culture-proven sepsis and blood transfusion. Clinicians should be aware of the presence of these risk factors when treating premature infants. Early detection and prevention of sepsis and reducing the number of blood transfusions may decrease the incidence of severe ROP requiring laser treatment. The identification of other risk factors that might be associated with the severity of ROP warrants further investigation. Additional analysis of the risk factors for severe ROP will improve our understanding and ability to predict the development of severe ROP in extremely premature infants.
